Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Sandoz Ag
Sandoz Ag_20100114
  

Sandoz Ag patents

Recent patent applications related to Sandoz Ag. Sandoz Ag is listed as an Agent/Assignee. Note: Sandoz Ag may have other listings under different names/spellings. We're not affiliated with Sandoz Ag, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Sandoz Ag-related inventors




Date Sandoz Ag patents (updated weekly) - BOOKMARK this page
06/15/17Preparation of ertapenem intermediates
04/13/17Solid composition comprising amorphous sofosbuvir
02/16/17Recombinant host cell for expressing proteins of interest
02/02/17Solid dispersion comprising an orexin receptor antagonist
02/02/17Recombinant host cell engineered to overexpress helper proteins
12/01/16Pharmaceutical composition comprising apixaban
12/01/16Apparatus for simulating the function of human stomach and/or human intestine
11/24/16Method for refolding recombinantly produced polypeptides
10/13/16Crystalline forms of ponatinib hydrochloride
09/15/16Preparation of micafungin intermediates
09/08/16Formulations containing amorphous dapagliflozin
07/28/16Synthesis of peptide epoxy ketones
07/14/16Novel crystalline forms of ceftaroline fosamil
07/14/16Microparticles for cell disruption and/or biomolecule recovery
07/07/16Novel adsorbent composition and use thereof
07/07/16Stereoselective synthesis of diols and triols by mannich reaction and their use in the synthesis of carfilzomib
06/30/16Method for the purification of epothilones via crystallization
06/30/16Method for the purification of epothilones via crystallization
06/23/16Method for preparing silodosin
06/16/16Improved process for the preparation of crystalline form iv of posaconazole
06/02/16Powder mixtures for antibiotic dry syrup formulations
05/05/16Compositions including cabazitaxel
05/05/16The process for the preparation of a pharmaceutical composition comprising rivaroxaban
04/21/16Tablet with increased drug load of odanacatib
04/07/16Stabilized liquid formulation
03/24/16Tablet with increased drug load of odanacatib
03/17/16Pharmaceutical composition containing crystalline macitentan
02/18/16Novel process for preparing ceftaroline fosamil
02/11/16Novel forms of telaprevir
01/21/16Quantification of misfolded tnfr2:fc
01/14/16Novel process for preparing ceftaroline fosamil
12/17/15Crystalline form of linaclotide
10/01/15Preparation of ertapenem intermediates
09/24/15Novel crystalline form of vortioxetine hydrobromide
09/03/15Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid
08/13/15Stable pharmaceutical composition containing 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1h-purine-2,6-dione or a pharmaceutically acceptable salt thereof
07/02/15Synthesis of telaprevir and boceprevir, or pharmaceutically acceptable salts or solvates as well as intermediate products thereof including beta-amino acids prepared via mukaiyama aldol addition
06/18/15Pharmaceutical compositions comprising crystalline posaconazole
06/18/15Crystalline form of masitinib
05/28/15Method for producing a recombinant protein of interest
03/19/15Pharmaceutical composition containing crystalline sorafenib tosylate
03/12/15Novel process for preparing ceftaroline fosamil
02/05/15Process for the synthesis of telaprevir, or pharmaceutically acceptable salts or solvates as well as intermediate products thereof
02/05/15Method for preparing silodosin
01/15/15Process for the preparation of form iii of vilazodone hydrochloride
11/13/14Acetone solvate of ivabradine hydrochloride
11/06/14Preparation of micafungin intermediates
10/09/14Process for the preparation of a chiral compound
10/02/14Long-term storage of non-glycosylated recombinant human g-csf
10/02/14Method of preparing polymorphic pure form a of bazedoxifene acetate
07/31/14Method for the preparation of substituted oxazolidinones
07/17/14Crystal forms of saxagliptin
07/10/14Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein
06/19/14Method for producing a recombinant protein of interest
06/19/14Method for producing a recombinant protein of interest
06/12/14Novel crystalline salts of asenapine
05/15/14Crystalline sodium salt of an hiv integrase inhibitor
05/08/14Novel crystalline salts of asenapine with organic di-acids and tri-acids
05/01/14Polymorph of linagliptin benzoate
05/01/14Novel crystalline asenapine hydrochloride salt forms
03/20/14Regioselective acylation of rapamycin at the c-42 position
09/19/13Crystalline form of rivaroxaban dihydrate
08/15/13Process for the preparation of chiral triazolones
08/15/13Purification of posaconazole and of posaconazole intermediates
08/08/13Process for the preparation of chiral hydrazides
Patent Packs
08/08/13Preparation of posaconazole intermediates
07/18/13Method for the preparation of rivoraxaban
06/27/13Long-term storage of non-glycosylated recombinant human g-csf
05/30/13Polymorphs of an active pharmaceutical ingredient
03/07/13Transcription terminator sequences
01/31/13Caspofungin formulations
01/10/13Crystalline forms of tigecycline hydrochloride
10/11/12Promoter sequences
10/04/12Processes for the synthesis of bazedoxifene acetate and intermediates thereof
09/13/12Reduction of organic compounds with low amounts of hydrogen
06/28/12Method for the preparation of w-amino- alkaneamides and w-amino-alkanethioamides as well as intermediates of this method
06/28/12Process for the preparation of indoline derivatives and their intermediates thereof
06/07/12Crystalline compound of 7-[(3r)-3-amino-1-oxo-4-(2, 4, 5-trifluorphenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri fluormethyl)-1, 2, 4 -triazolo[4,3-a]pyrazin
05/31/12Process for preparation of endothelial receptor antagonist (bosentan)
05/17/12Pharmaceutical composition containing 1h-inden-1-amine, 2,3-dihydro-n-2-propynyl-(1r)-, methanesulfonate
Patent Packs
05/17/12Insecticidal compound
05/10/12Method for the production of ceftobiprole medocaril
05/03/12Organic compounds
05/03/12Method for the production of ceftobiprole medocaril
04/26/12Crystalline form of posaconazole
04/12/12Crystal forms of saxagliptin
02/23/12Long-term storage of non-glycosylated recombinant human g-csf
01/26/12Crystalline form c of tigecycline dihydrochloride and methods for its preparation
12/29/11Method and device for oral application of a composition
12/15/11Crystalline form of an organic compound
08/04/11Process for the preparation of s-clopidogrel
07/21/11Capsule with soluble blocking element
07/21/11Improved process for the production of bimatoprost
07/07/11Process for the stereoselective enzymatic hydrolysis of 5-methyl-3-nitromethyl-hexanoic acid ester
06/09/11Preparation of microbiologically produced ergot alkaloids
05/26/11Method for processing microbiologically produced cyclic oligopeptides
05/26/11Antibiotic compounds
05/05/11Pharmaceutical compositions containing a crystalline form of posaconazole
05/05/11Crystalline forms of tigecycline hydrochloride
03/17/11A crystalline form of posaconazole
02/24/11Method for producing a recombinant protein on a manufacturing scale
02/17/11Process for the production of telithromycin
01/20/11Organic compounds
01/13/11Preparation of morpholine derivatives
01/13/11Carbonyl asymmetric alkylation
10/07/10Novel solvate
08/12/10Salt preparation
06/17/10Pharmaceutical compositions of poorly soluble drugs
03/11/10Device for the oral application of a substance
01/14/10Process for the production of prostaglandins and prostaglandin analogs
Social Network Patent Pack
08/13/09Organic compounds
08/06/09Crystalline form of cinacalcet
07/23/09Lyophilization process
06/25/09Promoter sequences
06/11/09Process for the preparation of substituted phenyl ether compounds
04/16/09Crystalline form of perindopril erbumine
01/14/10Process for the production of prostaglandins and prostaglandin analogs







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Sandoz Ag in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Sandoz Ag with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';